Brain histamine and oleoylethanolamide restore behavioral deficits induced by chronic social defeat stress in mice.
Histidine decarboxylase
Oxytocin
Recognition memory
Social interaction
T-pattern analysis
Journal
Neurobiology of stress
ISSN: 2352-2895
Titre abrégé: Neurobiol Stress
Pays: United States
ID NLM: 101643409
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
24
09
2020
revised:
19
02
2021
accepted:
07
03
2021
entrez:
19
4
2021
pubmed:
20
4
2021
medline:
20
4
2021
Statut:
epublish
Résumé
The physiological mechanisms underlying the complex interplay between life stressors and metabolic factors is receiving growing interest and is being analyzed as one of the many factors contributing to depressive illness. The brain histaminergic system modulates neuronal activity extensively and we demonstrated that its integrity is necessary for peripheral signals such as the bioactive lipid mediator oleoylethanolamide (OEA) to exert its central actions. Here, we investigated the role of brain histamine and its interaction with OEA in response to chronic social defeat stress (CSDS), a preclinical protocol widely used to study physio-pathological mechanisms underlying symptoms observed in depression. Both histidine decarboxylase null (HDC
Identifiants
pubmed: 33869681
doi: 10.1016/j.ynstr.2021.100317
pii: S2352-2895(21)00025-4
pmc: PMC8039856
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100317Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Br J Pharmacol. 2020 Feb;177(3):570-579
pubmed: 30714121
Neuropharmacology. 2013 Jul;70:131-40
pubmed: 23380305
Brain Behav Immun. 2019 Jul;79:102-113
pubmed: 30707932
Nat Rev Neurosci. 2013 Jul;14(7):472-87
pubmed: 23783198
Respir Physiol. 2001 Dec;129(1-2):191-209
pubmed: 11738654
Neuron. 2014 Jan 8;81(1):77-90
pubmed: 24411733
J Pharmacol Exp Ther. 1971 Dec;179(3):619-33
pubmed: 5138032
Neuropsychopharmacology. 2020 Oct;45(11):1931-1941
pubmed: 32353860
Neuropharmacology. 2016 Oct;109:139-147
pubmed: 27291828
Biol Psychiatry. 2016 Feb 1;79(3):213-21
pubmed: 26208744
Biol Psychiatry. 2007 Nov 15;62(10):1103-10
pubmed: 17511970
ACS Chem Neurosci. 2016 Mar 16;7(3):407-14
pubmed: 26765065
Int J Neuropsychopharmacol. 2017 May 1;20(5):392-399
pubmed: 28339575
Trends Neurosci. 2012 Nov;35(11):649-59
pubmed: 22974560
Nature. 2003 Sep 4;425(6953):90-3
pubmed: 12955147
Psychoneuroendocrinology. 2012 Jun;37(6):729-41
pubmed: 21783325
Physiol Behav. 2020 Dec 1;227:113138
pubmed: 32805221
Nat Protoc. 2011 Jul 21;6(8):1183-91
pubmed: 21799487
Transl Psychiatry. 2017 Jan 24;7(1):e1013
pubmed: 28117842
Pharmacol Res. 2016 Nov;113(Pt A):100-107
pubmed: 27543461
Synapse. 2002 Mar 15;43(4):238-43
pubmed: 11835518
Front Syst Neurosci. 2012 May 04;6:33
pubmed: 22586376
eNeuro. 2018 Apr 16;5(2):
pubmed: 29662948
J Neurosci Methods. 2018 Dec 1;310:24-32
pubmed: 29935197
Behav Res Methods Instrum Comput. 2000 Feb;32(1):93-110
pubmed: 10758668
Nature. 2001 Nov 8;414(6860):209-12
pubmed: 11700558
Neuropharmacology. 2018 Jun;135:234-241
pubmed: 29596898
Cell Metab. 2019 Jan 8;29(1):91-102.e5
pubmed: 30318340
Biol Psychiatry. 2019 May 15;85(10):792-801
pubmed: 30503164
PLoS One. 2013 Jul 11;8(7):e67865
pubmed: 23874457
Proc Natl Acad Sci U S A. 2018 Oct 23;115(43):E10187-E10196
pubmed: 30301805
Proc Natl Acad Sci U S A. 2009 May 12;106(19):8027-31
pubmed: 19416833
Eur J Neurosci. 2010 Jun;31(11):2073-85
pubmed: 20529118
Pharmacol Biochem Behav. 2015 Jun;133:146-54
pubmed: 25864425
Psychopharmacology (Berl). 1979 Feb 28;60(3):253-9
pubmed: 108702
Proc Natl Acad Sci U S A. 2016 May 10;113(19):E2714-20
pubmed: 27118833
Eur Arch Psychiatry Clin Neurosci. 2014 Aug;264(5):459-63
pubmed: 24253425
Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jan 10;96:109731
pubmed: 31394140
Neuropharmacology. 2017 Feb;113(Pt A):533-542
pubmed: 27833003
Behav Brain Res. 2019 Jan 1;356:444-452
pubmed: 29902478
Pharmacol Biochem Behav. 1990 Sep;37(1):63-9
pubmed: 2263668
Neuropharmacology. 2005 Jun;48(8):1147-53
pubmed: 15910890
Endocrinology. 2006 Oct;147(10):4968-76
pubmed: 16794011
Peptides. 2013 Nov;49:21-6
pubmed: 23959001
Pharmacol Res. 2017 Aug;122:20-34
pubmed: 28535974
Physiol Behav. 2001 Jun;73(3):401-10
pubmed: 11438368
Nat Neurosci. 2017 Dec;20(12):1752-1760
pubmed: 29184215
Behav Processes. 2016 Mar;124:23-31
pubmed: 26679824
Front Pharmacol. 2015 Jun 26;6:137
pubmed: 26167152
Physiol Behav. 2020 Mar 1;215:112790
pubmed: 31870941
Neurobiol Stress. 2016 Oct 06;6:94-103
pubmed: 28229112
Proc Natl Acad Sci U S A. 2017 Jun 20;114(25):6599-6604
pubmed: 28584117
Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2536-42
pubmed: 25918368
J Neurosci Methods. 2015 Jan 15;239:34-46
pubmed: 25280983
J Neurosci. 2010 Jun 16;30(24):8096-101
pubmed: 20554860
Nat Rev Neurosci. 2015 May;16(5):290-304
pubmed: 25891510
Sci Rep. 2018 Oct 5;8(1):14881
pubmed: 30291258
Brain Res. 2013 Nov 20;1539:73-86
pubmed: 24096214
Proc Natl Acad Sci U S A. 2014 Aug 5;111(31):11527-32
pubmed: 25049422
Physiol Behav. 2020 Dec 1;227:113146
pubmed: 32827506
Eur J Neurosci. 2003 Dec;18(11):3069-79
pubmed: 14656302